BEIJING — Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. Read More
Source link
GE Aerospace Boosts Outlook With Aviation Holding Strong
The across-the-board forecast increase suggests air travel will remain strong despite the market turbulence caused by trade disputes, inflation and the conflict with Iran. The company, which does business as…





